SecurityPSCC / PowerShares Exchange-Traded Fund Trust II (73937B605)
IndustryTelephone Communications, Except Radiotelephone
Institutional Owners4
Institutional Shares5,829 - 0.03%
Common Stock Shares Outstanding22,628,578 shares (as of 2015-09-30)
Institutional Value$ 417,000 USD
Related PSTO / Powerstorm Holdings, Inc.

Institutional Stock Ownership and Shareholders

PSCC / PowerShares Exchange-Traded Fund Trust II Institutional Ownership

PowerShares Exchange-Traded Fund Trust II (NASDAQ:PSCC) has 4 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,829 shares. Largest shareholders include Commonwealth Equity Services, Inc, MetLife Securities, Inc, Ladenburg Thalmann Financial Services Inc, and Newfound Research LLC.
PowerShares Exchange-Traded Fund Trust II (NASDAQ:PSCC) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 100 0 -100.00 7 0 -100.00
2018-08-14 13F-HR MORGAN STANLEY 10,541 0 -100.00 738 0 -100.00
2018-08-07 13F-HR First Personal Financial Services 680 0 -100.00 48 0 -100.00
2018-08-14 13F-HR ROYAL BANK OF CANADA 7,702 0 -100.00 539 0 -100.00
2018-08-14 13F-HR UBS Group AG 79 0 -100.00 6 0 -100.00
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. 1 0 -100.00 0 0
2018-08-02 13F-HR D.A. DAVIDSON & CO. 23,600 0 -100.00 1,651 0 -100.00
2017-01-13 13F-HR MetLife Securities, Inc 750 1,076 43.47 49 74 51.02
2018-07-31 13F-HR Newfound Research LLC 196 196 0.00 14 16 14.29
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 8,358 4,166 -50.16 557 300 -46.14
2018-07-30 13F-HR/A Virtu Financial LLC 12,049 0 -100.00 840 0 -100.00
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 153 0 -100.00 11 0 -100.00
2018-08-13 13F-HR ADVANTAGE INVESTMENT MANAGEMENT, LLC 13 0 -100.00 1 0 -100.00
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 5,297 0 -100.00 371 0 -100.00
2018-08-13 13F-HR MML INVESTORS SERVICES, LLC 3,734 0 -100.00 261 0 -100.00
2018-08-14 13F-HR LPL Financial LLC 15,993 0 -100.00 1,119 0 -100.00
2018-08-07 13F-HR SG Americas Securities, LLC 4,229 0 -100.00 295 0 -100.00
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 13,116 0 -100.00 917 0 -100.00
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 2,222 0 -100.00 155 0 -100.00
2018-08-13 13F-HR RAYMOND JAMES & ASSOCIATES 7,695 0 -100.00 538 0 -100.00
2018-08-13 13F-HR Advisor Group, Inc. 1,906 0 -100.00 133 0 -100.00
2018-07-18 13F-HR Jackson Financial Management 22,040 0 -100.00 1,542 0 -100.00
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 9,342 0 -100.00 654 0 -100.00
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 3,528 0 -100.00 246 0 -100.00
2018-08-03 13F-HR WRAPMANAGER INC 6,459 0 -100.00 452 0 -100.00
2018-08-10 13F-HR ENVESTNET ASSET MANAGEMENT INC 1,217 0 -100.00 85 0 -100.00
2018-08-15 13F-HR JANE STREET GROUP, LLC 17,954 0 -100.00 1,256 0 -100.00
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 12,033 0 -100.00 839 0 -100.00
2018-08-14 13F-HR UNITED CAPITAL FINANCIAL ADVISERS, LLC 23,587 0 -100.00 1,650 0 -100.00
2018-08-14 13F-HR AllSquare Wealth Management LLC 127 0 -100.00 9 0 -100.00
2018-08-13 13F-HR Pacific Sun Financial Corp 12,423 0 -100.00 869 0 -100.00
2018-08-13 13F-HR Asset Dedication, LLC 225 0 -100.00 16 0 -100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,991 0 -100.00 1,812 0 -100.00
2018-08-10 13F-HR Cambridge Investment Research Advisors, Inc. 3,702 0 -100.00 259 0 -100.00
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 391 391 0.00 27 27 0.00
2018-08-08 13F-HR US BANCORP \DE\ 400 0 -100.00 28 0 -100.00

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

How Contrarian Are You? My Foray Into Consumer Staples

2018-07-10 seekingalpha
Consumer staples has been one of the most cast-off sectors of the 2010s, and many companies are trading at cheap multiples. (17-0)

9 Sector ETFs That Braved Trade Turmoil in Q2

2018-06-27 investorplace
As we are drawing close to the trade-tension-wreaked second quarter of 2018, a look at winning sector ETFs makes sense. Not only trade, the quarter has seen hawkish central bank activities, political turmoil in Europe and acute emerging market selloffs. (16-0)

4 Best-Performing Sector ETFs from May

2018-05-31 investorplace
The popular adage “Sell in May and Go Away” proved wrong this year as Wall Street is on track to log the best May in nine years. With just one trading session left to the month, the S&P 500 gained 3.3%, Dow Jones is up 3.1%, and Nasdaq Composite Index has moved up by 5.1% in May. (25-0)

CUSIP: 73937B605